Are there age restrictions for medical cannabis use in PMR patients?

PostedFebruary 23, 2026

UpdatedFebruary 23, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Polymyalgia rheumatica (PMR) mainly affects older adults, but rules for accessing cannabis as part of treatment can vary depending on location. Understanding cannabis age restrictions for PMR is important for patients and caregivers considering this option.

Key Considerations for Age and Access

Regulations often outline who can legally use cannabis in medical contexts. These rules usually include minimum age for cannabis use, adult consent requirements, and specific frameworks for younger patients.

Minimum Age for Cannabis Use

In most countries, a minimum age for cannabis use is set, commonly 18 or 21. This ensures that cannabis is primarily accessed by adults with medical needs rather than younger populations.

Adult Use Requirements

Many systems apply adult use requirements, meaning only legal adults can directly obtain a prescription. Older adults with PMR generally meet this requirement without issue.

Paediatric Considerations in PMR

Although PMR rarely affects young people, where it does, paediatric considerations in PMR are vital. In such cases, prescriptions usually require specialist oversight, stricter regulations, and parental consent.

Age plays a crucial role in regulating access to medical cannabis. Patients must follow cannabis age restrictions for PMR, which typically involve meeting the minimum age for cannabis use, complying with adult use requirements, and accounting for rare paediatric considerations in PMR. These safeguards aim to balance access with safety.

If you’re exploring cannabis treatment options for polymyalgia rheumatica, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and polymyalgia rheumatica .

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.